XBiotech Inc.
XBIT · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Simard Jan-Paul: Form 4
Insider disclosure · Filed · Report period 26 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 3
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K/A
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- XBIT · 98400H102 - Common Shares, no par value
Company details and SEC sources
CIK 0001626878 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- XBIT on Nasdaq
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 5217 Winnebago Lane, Austin, TX, 78744
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields